Prevalence of lymphedema symptoms across cancer diagnoses and association with depression, pain interference and health-related quality of life.

ABSTRACT:

Background and purpose

Lymphedema is a debilitating late effect of cancer treatments, yet its prevalence beyond breast cancer remains understudied. This study examined the prevalence of lymphedema symptoms across cancer diagnoses and their association with depression, pain interference, and health-related quality of life (HRQoL).

Patients/material and methods

This cross-sectional study was conducted at the Department of Oncology, Copenhagen University Hospital, from February to April 2021, as part of a broader investigation into cancer-related late effects. Here, we present data from patients in follow-up who received online lymphedema symptom assesments (swelling, heaviness, or tightness). Utilized questionnaires were the European Organization for Research and Treatment of

SUBMITTER: Larsen GS 

PROVIDER: S-EPMC11776255 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature